Table 1 Immunophenotypic and cytogenetic... | American Society of Hematology

Table 1

Immunophenotypic and cytogenetic characteristics of the SMZL cases

Case	Sex	Age, y	Immunophenotype	Cytogenetic findings
Case 10	Male	55	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	46,XY,t(4;14)(p13;q32),dup(12)(q14q23)[15]
Case 25	Female	56	CD19⁺, CD20⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	47,XX,⁺3[4]/46,XX[10]
Case 103	Female	55	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	46,XX[25]
Case 129	Female	52	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5-, CD10-	46,XX,del(7)(q33),add(13)(p13),add(14)(q32)[3]/46,XX[2]
Case 152	Female	51	CD19⁺, CD20⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻	47,XX,⁺add(3)(p21),del(7)(q11q22orq22q32)[8]/46,XX[7]
Case 255	Female	62	CD19⁺, CD20⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻	47,XX,⁺X,der(15)t(11;15)[4]/47,XX,⁺add(12)(p11)[2]/46,XX[2]

Case	Sex	Age, y	Immunophenotype	Cytogenetic findings
Case 10	Male	55	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	46,XY,t(4;14)(p13;q32),dup(12)(q14q23)[15]
Case 25	Female	56	CD19⁺, CD20⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	47,XX,⁺3[4]/46,XX[10]
Case 103	Female	55	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻, CD23⁻	46,XX[25]
Case 129	Female	52	CD19⁺, CD20⁺, CD22⁺, FMC7⁺, IgM⁺, IgK⁺, CD5-, CD10-	46,XX,del(7)(q33),add(13)(p13),add(14)(q32)[3]/46,XX[2]
Case 152	Female	51	CD19⁺, CD20⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻	47,XX,⁺add(3)(p21),del(7)(q11q22orq22q32)[8]/46,XX[7]
Case 255	Female	62	CD19⁺, CD20⁺, FMC7⁺, IgM⁺, IgK⁺, CD5⁻, CD10⁻	47,XX,⁺X,der(15)t(11;15)[4]/47,XX,⁺add(12)(p11)[2]/46,XX[2]